Atrial fibrillation and stroke in the perspective of new oral anticoagulants

Atrial fibrillation and stroke in the perspective of new oral anticoagulants

Atrial fibrillation is an independent, powerful risk factor for stroke. Until recently, acetyl salicylic acid (aspirin) and warfarin were the only approved treatment options for stroke prophylaxis. Although warfarin provides a significantly better risk reduction in stroke compared to placebo and a...

Full description

Bibliographic Details
Main Authors: Demet Funda Baş, Mehmet Akif Topçuoğlu, Ethem Murat Arsava
Format: Article
Language:English
Published: Turkish Society of Cerebrovascular Diseases 2013-02-01
Series:Türk Beyin Damar Hastalıkları Dergisi
Subjects:
Stroke
atrial fibrillation
anticoagulant
dabigatran
apixaban
rivaroxaban
warfarin.
Online Access:http://www.journalagent.com/tbdhd/pdfs/TBDHD-33042-REVIEW-BAS.pdf

Similar Items

Similar Items